Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLAIN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GTSE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CENPBD1P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MFSD8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF200 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORA17B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLCN6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMLN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101929368 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIOK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCCC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OCIAD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPH7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP48 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NELFB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBX1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THAP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on